OTC : DMPHF

Dermapharm Holding SE

$53 USD

$0 (0.0%)

Volume
100
Average Volume
1
Market Capitalization
$2.63B
P/E Ratio
15.69
Dividend Yield
2.09%
Price Target
Year High
$53.00
Year Low
$39.56
Day High
—
Day Low
—
Payout Ratio
$0.34
Current Ratio
$2.00
Company Overview

OTC

Hans-Georg Feldmeier

Drug Manufacturers - Specialty & Generic

Healthcare

DMPHF

3610

DE

USD

https://www.dermapharm.de

49 89 6 41 86 0

N/A

N/A

Liquidity Metrics

1.41

2.00

1.08

0.58

0.34

Sales & Valuation

$1.16B

1.79

3.08

10.54

3.68

Profitability

$2.46

$132.36M

12.34%

16.72%

21.44%

6.35%

P/E Metrics

15.69

0.39

0.39

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

2.30

6/9

$391.29M

$2.28B

$1.54B

$240.32M

Key Metrics (TTM)

$2.9B

2.49

8.72

2.00

21.44%

8.55%

6.35%

9.49%

$28.76

177 days

Company Executives
Name Title
Christof Dreibholz Chief Financial Officer, Chief Compliance Officer & Member of Management Board
Hans-Georg Feldmeier Chief Executive Officer & Chairman of the Management Board
Britta Hamberger Head of Investor Relations & Corporation Communications
Andreas Eberhorn Chief Marketing Officer & Member of Management Board
Poll Results

No votes yet today — be the first to share your view!

About Dermapharm Holding SE (OTC:DMPHF) Stock

Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Imports, and Herbal Extracts. The company's comprehensive activities encompass the development, production, licensing, marketing, and distribution of its offerings. Its product range includes reputable generic drugs, non-prescription remedies, natural over-the-counter treatments, and a variety of other health products. These target diverse medical fields, such as vitamin and mineral supplementation, nutritional support, skin conditions (dermatology), allergies, pain relief, cardiovascular health, women's health (gyne ... cology), and urological issues. Key brands in its portfolio feature Dekristol, Dekristolvit, Allergovit, and Tromcardin. Additionally, Dermapharm provides medical devices like bite away and Herpotherm, alongside specific treatments such as the Momekort nasal spray for allergy symptoms and Azedil, available as a nasal spray or eye drops. Within its Parallel Imports division, Dermapharm brings original pharmaceuticals to market under the axicorp brand. The Herbal Extracts segment supplies natural active ingredients and botanical extracts primarily for phytopharmaceuticals, nutraceuticals, and cosmetic applications. The company's distribution network reaches pharmaceutical wholesalers, individual pharmacies, hospitals, and health food stores. Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

Frequently Asked Questions

What is the current Dermapharm Holding SE (DMPHF) stock price?

Dermapharm Holding SE(OTC:DMPHF) stock price is $53 in the last trading session. During the trading session, DMPHF stock reached the peak price of $53 while $39.56 was the lowest point it dropped to. The percentage change in DMPHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in DMPHF stock was $0.

DMPHF's industry and sector of operation?

The OTC listed DMPHF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of DMPHF?

Christof Dreibholz | Chief Financial Officer, Chief Compliance Officer & Member of Management Board
Hans-Georg Feldmeier | Chief Executive Officer & Chairman of the Management Board
Britta Hamberger | Head of Investor Relations & Corporation Communications
Andreas Eberhorn | Chief Marketing Officer & Member of Management Board
|

How many employees does DMPHF have?

Number of DMPHF employees currently stands at 3610. DMPHF operates from Lil-Dagover-Ring 7, Grünwald, BV 82031, DE.

Link for DMPHF official website?

Official Website of DMPHF is: https://www.dermapharm.de

How do I contact DMPHF?

DMPHF could be contacted at phone #49 89 6 41 86 0 and can also be accessed through its website. DMPHF operates from Lil-Dagover-Ring 7, Grünwald, BV 82031, DE.

How many shares of DMPHF are traded daily?

The average number of DMPHF shares traded daily for last 3 months was 1.

What is the market cap of DMPHF currently?

The market value of DMPHF currently stands at $2.63B with its latest stock price at $53